Shock and flex: new combo therapy aims to restore ankle movement after stroke

NCT ID NCT07458750

First seen Jun 24, 2026 · Last updated Jun 24, 2026

Summary

This study tests whether combining neuromuscular electrical stimulation (NEMS) with voluntary muscle contraction can improve ankle function in people with chronic stroke. Twenty-five participants will either receive conventional physiotherapy or NEMS plus active dorsiflexion exercises. Researchers will measure spasticity, range of motion, and muscle strength over 12 weeks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • University of lahore teaching hospital

    Lahore, Punjab Province, 54000, Pakistan

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

neuromuscular electrical stimulation (NEMS) combined with voluntary muscle contraction

What this could lead to

If it works, this could point toward a simple, non-drug therapy to improve ankle movement and reduce stiffness in people who have had a stroke.

What could go wrong

This is a small, early-stage trial with only 25 participants, so results may not apply to everyone. The improvements measured are small-scale (range of motion, spasticity) and may not translate to major functional gains.

Conditions

The condition(s) this trial relates to.

hemiplegia stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.